L&C BIO Co.,LTD (KOSDAQ:290650)

South Korea flag South Korea · Delayed Price · Currency is KRW
23,200
+700 (3.11%)
May 13, 2025, 3:30 PM KST
10.21%
Market Cap 526.29B
Revenue (ttm) 72.09B
Net Income (ttm) 141.06B
Shares Out 22.68M
EPS (ttm) 5,637.05
PE Ratio 4.05
Forward PE n/a
Dividend 50.00 (0.22%)
Ex-Dividend Date Dec 27, 2024
Volume 60,227
Average Volume 72,191
Open 22,250
Previous Close 22,500
Day's Range 21,950 - 23,350
52-Week Range 15,000 - 27,450
Beta 0.57
RSI 63.02
Earnings Date May 12, 2025

About L&C BIO Co.,LTD

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. It offers human tissue, medical device, and cosmetics products. The company was founded in 2011 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2011
Employees 130
Stock Exchange KOSDAQ
Ticker Symbol 290650
Full Company Profile

Financial Performance

In 2024, L&C BIO Co.,LTD's revenue was 72.09 billion, an increase of 9.35% compared to the previous year's 65.93 billion. Earnings were 141.06 billion, an increase of 191.69%.

Financial Statements

News

There is no news available yet.